J Korean Med Sci.  2015 Apr;30(4):456-462. 10.3346/jkms.2015.30.4.456.

Risk Factors for Late-onset Hyponatremia and Its Influence on Neonatal Outcomes in Preterm Infants

• Kim YJ
• Lee JA
• Oh S
• Choi CW
• Kim EK
• Kim HS
• Kim BI
• Choi JH

• KMID: 2164454
• DOI: http://doi.org/10.3346/jkms.2015.30.4.456

Abstract

Late-onset hyponatremia (LOH), hyponatremia occurring after two weeks of age with the achievement of full feeding, is the result of a negative sodium balance caused by inadequate salt intake or excessive salt loss due to immature renal or intestinal function in preterm infants. The aims of our study were to identify the risk factors for LOH and its influence on neonatal outcomes. This was a retrospective cohort analysis of 161 preterm infants born before 34 weeks of gestation between June 2009 and December 2010 at Seoul National University Hospital. LOH was defined as a sodium level < or = 132 mEq/L or 133-135 mEq/L with oral sodium supplementation. LOH occurred in 49 (30.4%) of the studied infants. A lower gestational age, a shorter duration of parenteral nutrition, the presence of respiratory distress syndrome, the use of furosemide, and feeding with breast milk were significant risk factors for LOH. In terms of neonatal outcomes, the infants with LOH had longer hospital stays and higher risks of bronchopulmonary dysplasia and retinopathy of prematurity requiring surgery. LOH lasting at least 7 days significantly increased moderate to severe bronchopulmonary dysplasia, periventricular leukomalacia, and extra-uterine growth retardation. LOH is commonly observed in preterm infants; it may be a risk factor for bronchopulmonary dysplasia and retinopathy of prematurity or a marker of illness severity.

Keyword

Hyponatremia; Premature Infant; Prematurity; Risk Factors; Outcome

MeSH Terms

Bronchopulmonary Dysplasia/etiology
Cohort Studies
Female
Humans
Hyponatremia/*etiology
Infant, Newborn
Infant, Premature
Logistic Models
Male
Retrospective Studies
Risk Factors

Reference

1. Kovács L, Sulyok E, Lichardus B, Mihajlovskij N, Bircak J. Renal response to arginine vasopressin in premature infants with late hyponatraemia. Arch Dis Child. 1986; 61:1030–1032.

2. Polin RA. Renal aspects of sodium metabolism in the fetus and neonate. In : Oh W, Guignard JP, Baumgart S, Polin RA, editors. Nephrology and fluid/electrolyte physiology: neonatology questions and controversies. Philadelphia: Saunders/Elsevier;2008. p. 42–44.

3. Sulyok E, Varga F. Renal aspects of neonatal sodium homeostasis. Acta Paediatr Hung. 1983; 24:23–35.

4. Fine BP, Ty A, Lestrange N, Levine OR. Sodium deprivation growth failure in the rat: alterations in tissue composition and fluid spaces. J Nutr. 1987; 117:1623–1628.

5. Al-Dahhan J, Haycock GB, Nichol B, Chantler C, Stimmler L. Sodium homeostasis in term and preterm neonates. III. Effect of salt supplementation. Arch Dis Child. 1984; 59:945–950.

6. Moritz ML, Ayus JC. Hyponatremia in preterm neonates: not a benign condition. Pediatrics. 2009; 124:e1014–e1016.

7. Ertl T, Hadzsiev K, Vincze O, Pytel J, Szabo I, Sulyok E. Hyponatremia and sensorineural hearing loss in preterm infants. Biol Neonate. 2001; 79:109–112.

8. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001; 163:1723–1729.

9. Al-Dahhan J, Jannoun L, Haycock GB. Effect of salt supplementation of newborn premature infants on neurodevelopmental outcome at 10-13 years of age. Arch Dis Child Fetal Neonatal Ed. 2002; 86:F120–F123.

10. Murphy DJ, Hope PL, Johnson A. Neonatal risk factors for cerebral palsy in very preterm babies: case-control study. BMJ. 1997; 314:404–408.

11. Abman SH, Rosenberg AA, Lum GM. Management of hyponatremia in infants with bronchopulmonary dysplasia. J Pediatr. 1988; 113:789–790.

12. Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2008; CD000503.

13. Lichardus B, Sulyok E, Kovács L, Michajlovskij N, Lehotská V, Némethová V, Varga L, Ertl T. Renal salt-wasting increases vasopressin excretion in preterm infants. Monogr Neural Sci. 1986; 12:179–184.

14. Sulyok E, Kovács L, Lichardus B, Michajlovskij N, Lehotska V, Némethova V, Varga L, Ertl T. Late hyponatremia in premature infants: role of aldosterone and arginine vasopressin. J Pediatr. 1985; 106:990–994.

15. Kojima T, Fukuda Y, Hirata Y, Matsuzaki S, Kobayashi Y. Changes in vasopressin, atrial natriuretic factor, and water homeostasis in the early stage of bronchopulmonary dysplasia. Pediatr Res. 1990; 27:260–263.

16. Hazinski TA, Blalock WA, Engelhardt B. Control of water balance in infants with bronchopulmonary dysplasia: role of endogenous vasopressin. Pediatr Res. 1988; 23:86–88.

17. Haycock GB. The influence of sodium on growth in infancy. Pediatr Nephrol. 1993; 7:871–875.

18. Murthy JN, Hicks JM, Soldin SJ. Evaluation of i-STAT portable clinical analyzer in a neonatal and pediatric intensive care unit. Clin Biochem. 1997; 30:385–389.

19. Papadea C, Foster J, Grant S, Ballard SA, Cate JC 4th, Southgate WM, Purohit DM. Evaluation of the i-STAT Portable Clinical Analyzer for point-of-care blood testing in the intensive care units of a university children's hospital. Ann Clin Lab Sci. 2002; 32:231–243.